• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease.

作者信息

Morris B J, Glenn C L, Wilcken D E, Wang X L

机构信息

Basic & Clinical Genomics Laboratory, Department of Physiology and Institute for Biomedical Research, The University of Sydney, NSW 2006, Sydney, Australia.

出版信息

Clin Sci (Lond). 2001 May;100(5):551-6.

PMID:11294696
Abstract

Pathophysiological processes in coronary artery disease (CAD) are influenced by genetic factors. Since (i) inducible nitric oxide synthase (iNOS) has important cardiovascular effects, and (ii) the promoter of the iNOS gene (NOS2A) is genetically modulated by a 4 bp insertion/deletion (+/-) polymorphism located 0.7 kb upstream, we decided to examine the influence of this variant on clinical variables in 856 CAD patients of Anglo-Celtic/Northern European extraction. We found that 2% of CAD patients were homozygous for the + allele, and 19% were heterozygous. Males made up 74% of the patient group, and in these the + allele was associated with 38% higher plasma glucose levels (P=0.005), a 4.8% elevation in the waist/hip ratio (P=0.009) and a 48% greater frequency of unstable angina (P=0.014). The + allele, by influencing iNOS expression, could thus contribute to indices of insulin resistance and angina severity in male CAD patients.

摘要

相似文献

1
Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease.
Clin Sci (Lond). 2001 May;100(5):551-6.
2
Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes.功能性诱导型一氧化氮合酶启动子变体与2型糖尿病并发症的关联。
J Mol Med (Berl). 2002 Feb;80(2):96-104. doi: 10.1007/s00109-001-0287-1. Epub 2001 Oct 5.
3
Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease.
Am Heart J. 2001 Oct;142(4):586-9. doi: 10.1067/mhj.2001.118113.
4
Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls.智利冠心病患者及对照人群中内皮型一氧化氮合酶G894T基因多态性
Clin Chim Acta. 2006 Sep;371(1-2):102-6. doi: 10.1016/j.cca.2006.02.030. Epub 2006 Mar 2.
5
Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.多发性硬化症人群中诱导型一氧化氮合酶基因(NOS2A)多态性的研究。
Brain Res Bull. 2004 Jul 30;64(1):9-13. doi: 10.1016/j.brainresbull.2004.04.019.
6
Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.诱导型一氧化氮合酶基因启动子多态性与诱导型一氧化氮合酶的胃mRNA表达增加及胃癌风险增加相关。
Eur J Gastroenterol Hepatol. 2007 Feb;19(2):139-45. doi: 10.1097/01.meg.0000252637.11291.1d.
7
Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease.内皮型一氧化氮合酶表达对剪切应力不敏感作为冠心病的一个遗传危险因素。
Circ Res. 2004 Oct 15;95(8):841-7. doi: 10.1161/01.RES.0000145359.47708.2f. Epub 2004 Sep 16.
8
[Allelic polymorphism of endothelial NO-synthase (T(-786)-->C) promoter gene as risk factor of acute coronary syndrome].
Fiziol Zh (1994). 2005;51(1):72-6.
9
The importance of the (TAAAA)n alleles at the SHBG gene promoter for the severity of coronary artery disease in postmenopausal women.性激素结合球蛋白(SHBG)基因启动子处的(TAAAA)n等位基因对绝经后女性冠状动脉疾病严重程度的重要性。
Menopause. 2008 May-Jun;15(3):461-8. doi: 10.1097/gme.0b013e31814faf41.
10
[Frequencies of allelic polymorphism of endothelial NO-synthase gene in patients with acute coronary syndrome in Ukrainian population].
Tsitol Genet. 2005 Mar-Apr;39(2):49-54.

引用本文的文献

1
Regulation of obesity and insulin resistance by nitric oxide.一氧化氮对肥胖和胰岛素抵抗的调节作用
Free Radic Biol Med. 2014 Aug;73:383-99. doi: 10.1016/j.freeradbiomed.2014.05.016. Epub 2014 May 28.
2
Genetic risk score of NOS gene variants associated with myocardial infarction correlates with coronary incidence across Europe.与心肌梗死相关的一氧化氮合酶(NOS)基因变异的遗传风险评分与全欧洲的冠心病发病率相关。
PLoS One. 2014 May 7;9(5):e96504. doi: 10.1371/journal.pone.0096504. eCollection 2014.
3
Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy.
诱导型一氧化氮合酶启动子多态性可预防颈动脉内膜切除术后的认知功能障碍。
Stroke. 2009 May;40(5):1597-603. doi: 10.1161/STROKEAHA.108.541177. Epub 2009 Mar 12.
4
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis.一氧化氮合酶2A(NOS2A)的基因变异与多发性硬化症风险
Genes Immun. 2008 Sep;9(6):493-500. doi: 10.1038/gene.2008.41. Epub 2008 Jun 26.
5
Anti-atherosclerotic effects of vitamin E--myth or reality?维生素E的抗动脉粥样硬化作用——是神话还是现实?
J Cell Mol Med. 2004 Jan-Mar;8(1):59-76. doi: 10.1111/j.1582-4934.2004.tb00260.x.